[Effect of treatment with Encorton (Polfa), Solu-Medrol and Encorton and Cyclophosphamide and Encorton on the production of immunoglobulin G in the central nervous system in multiple sclerosis].
Ochudło
S
S
D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D006801:Humans; D007074:Immunoglobulin G / Q000096:biosynthesis / Q000134:cerebrospinal fluid*; D008775:Methylprednisolone / Q000031:analogs & derivatives*; D008776:Methylprednisolone Hemisuccinate / Q000008:administration & dosage*; D009103:Multiple Sclerosis / Q000134:cerebrospinal fluid / Q000188:drug therapy* / Q000276:immunology; D011044:Poland; D011241:Prednisone / Q000008:administration & dosage*
D007074:Immunoglobulin G; D008776:Methylprednisolone Hemisuccinate; D003520:Cyclophosphamide; D011241:Prednisone; D008775:Methylprednisolone
Wpływ leczenia Encortonem (Polfa), Solu-Medrolem i encortonem oraz Cyclophosphamidem i encortonem na produkcje immunoglobuliny G w orbebie ośrodkowego układu nerwowego w stwardnieniu rozsianym.